Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Sector Investor who wrote (401)	12/12/1997 12:27:00 PM
From: chirodoc	Read Replies (1) \| Respond to of 887

<<<<DR believes that DepoTech shares are currently undervalued based on the potential for DepoCyt and the planned aggressive development of its earlier- stage products. ......thanks!!!! .....there are not that many investors that realize what we do--all bios are not the same. the fact that some, like depo are working on novel ways of using already approved chemicals makes them much safer investments than the labs that are dreaming up new chemicals and are only starting PI/II trials. (with totally unknown products) ....nice to see that the street agrees with us